|60.17|| +0.67 / +1.13%|
Abbott Laboratories engages in the discovery, development, manufacture and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Vascular Products. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure and other medical device products. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
|Miles D. White||Chairman & Chief Executive Officer|
|Brian B. Yoor||Chief Financial Officer & Executive VP-Finance|
|Randel W. Woodgrift||VP-Abbott Medical Devices Cardiovascular|
|James E. Young||Chief Compliance & Ethics Officer, Vice President|
|Hubert L. Allen||Secretary, Executive VP & General Counsel|